CJC-1295 / Ipamorelin 5mg/5mg Blend
GHRH Analog + Ghrelin-Receptor Agonist Blend
A two-component research blend of CJC-1295 (a modified GRF(1-29) GHRH analog) and Ipamorelin (a selective ghrelin-receptor agonist), studied together within growth hormone-secretion research.
- COA included with every vial
- Free U.S. shipping over $200
- Secure encrypted checkout
- ≥99% doctoral chemist verified purity
RESEARCH APPLICATIONS
All products are intended strictly for in-vitro laboratory research and development use only. Not for human or veterinary use, not a drug, food, or cosmetic, and not intended to diagnose, treat, cure, or prevent any disease.
What is CJC-1295 / Ipamorelin studied for in research?
This blend combines CJC-1295, a modified GRF(1-29) analog of growth hormone-releasing hormone, with Ipamorelin, a selective pentapeptide agonist of the growth hormone secretagogue receptor. The two are studied together because they act on complementary arms of the somatotropic axis: CJC-1295 at the GHRH receptor and Ipamorelin at the ghrelin/GHS-R receptor. Component quantities are lot-specific and documented on the accompanying Certificate of Analysis.
Reconstitution & Handling
Reconstitute with bacteriostatic water. Do not shake vigorously.
Store at -20°C. Protect from light. Reconstitute and refrigerate.
Specifications
- Purity
- ≥99%
- Form
- Lyophilized powder
- Molecular Formula
- Blend (see COA)
- Molecular Weight
- Blend (see COA)
- CAS Number
- Blend (see COA)
- Strength
- 5mg/5mg Blend
Download the Certificate of Analysis
Doctoral chemist purity & identity report
You May Also Research
Tesamorelin 10mg
COA included, doctoral chemist tested
A stabilized growth hormone-releasing factor analog studied for its effects on GH secretion pathways in laboratory models.
GLP-3RT 20mg
COA included, doctoral chemist tested
A next-generation triple-receptor agonist studied within metabolic, glucose-regulation, and energy-homeostasis research pathways.
MOTS-C 10mg
COA included, doctoral chemist tested
A 16-residue mitochondrial-derived peptide studied within cellular-metabolism and AMPK-signaling research.
CJC-1295 / Ipamorelin Questions, Answered
What is in the CJC-1295 / Ipamorelin blend?
It combines CJC-1295 (a GHRH analog) and Ipamorelin (a selective ghrelin-receptor agonist) in a single lyophilized vial. Exact component quantities are documented on the accompanying Certificate of Analysis. It is for research use only.
Why are CJC-1295 and Ipamorelin studied together?
They act on complementary arms of the somatotropic axis, CJC-1295 at the GHRH receptor and Ipamorelin at the ghrelin/GHS-R receptor, which is why they are combined in a single research blend rather than reconstituted separately.
Does the blend have a single molecular formula?
No. As a multi-component blend it has no single formula or CAS number. The identity and quantity of each component are reported on the lot-matched Certificate of Analysis.